Key Takeaways
- Aerospace leads with 40% growth: Q1 FY27 aerospace revenue grew 40% YoY, ahead of the 25% committed rate, but EBITDA margin compressed from 23.7% to 21.2% as R&D was expensed to unlock that expansion.
- Precision Technology delivers margin leverage: Revenue grew 11% YoY while EBITDA margin expanded from 10.6% to 13.8%, driven by export ramp-up and operating leverage.
- Trade tailwinds are now structural: India-U.K. CETA eliminated tariffs up to 18% from July 2026, and U.S. tariff rollbacks restored North American trade clarity, both directly benefiting India-based precision suppliers.
- Order book visibility extended to 10 years: Aerospace order book stands at ₹5,960+ crores with an active RFQ pipeline of ₹1,632 crores; disclosure horizon was lengthened from 5 to 10 years.
- What to watch next quarter: Whether aerospace margins stabilize as promised, the commercial rollout of the automotive aftermarket line in Q2, and any concrete defence or medical strategy disclosures.
Aerospace: Growth vs. Margin Trade-off
- The growth engine: 40% YoY revenue expansion came from major production capacity expansion and higher realization across key aerospace OEMs and Tier 1 programs. Q1 exceeded the 25% committed growth rate.
- The margin cost: EBITDA margin fell from 23.7% to 21.2% YoY because all R&D expenses are written off in the same quarter with no capitalization. Increased speed of new product development drove the growth but pressured margins.
- The stabilization bet: Management expects margins to stabilize as newly developed programs transition to steady-state production. The mature-level aerospace EBITDA margin target is ~25%.
- Supply chain remains the binding constraint: Titanium and aerospace-grade alloy constraints persisted into late FY26 but raw material channels and engine production schedules gradually unblocked in Q1. Management noted the company is not exposed as much to casting/forging bottlenecks because those critical-side businesses have not transferred yet.
Maini: "The more backlog you clear, the larger the backlog gets, which also, gets me to feel that the supply chain is So, constrained that typically, if you do a good job, you'll just get more business. So, like I've always maintained, this is an execution game. And if you can execute the business correctly, you will always be in the winner's seat."
Precision Technology & Export Environment
- Export-led growth: 11% YoY revenue growth was primarily driven by ramp-up in export revenues, as global Tier 1 buyers actively rebuild inventory buffers.
- Operating leverage unlocked: EBITDA margin expanded from 10.6% to 13.8% YoY because volume growth unlocked substantial operating leverage, alongside targeted cost reduction initiatives.
- Near-term margin target: Management is looking at 12%–13% EBITDA margin in precision manufacturing in the near term.
- Cost pressures are real but manageable: Logistics costs, tooling costs (carbide and HSS), and minimum wage increases all hit during the quarter. Mitigation comes via efficiency, operating leverage, and customer discussions.
- Trade policy tailwinds: India-U.K. CETA entered into force on 15 July 2026, eliminating tariffs up to 18% on machinery, auto components, and metalwork. U.S. tariff rollbacks earlier this year restored trade clarity to the North American corridor.
Maini: "The bigger thing is China Plus One because I think what business would probably be going to China much more than that would come to India."
Order Book & Pipeline
- Longer visibility: The company changed order book disclosure from a 5-year horizon to a 10-year horizon to give longer visibility. Aerospace order book stands at ₹5,960+ crores with an active RFQ pipeline of ₹1,632 crores.
- Daily growth: Order book is point-in-time and grows daily; current order book covers only the existing facility, not the under-construction greenfield.
- RFQ conversion is a choice, not a constraint: Management did not answer whether the company is L1 in any RFQ pipeline orders or provide a conversion timeline, instead describing the process as a daily growth business where the company can choose businesses with the right margins, ROCE, and production fit.
- Bidding horizon extends to 2030: The company is bidding on products that will come in 2029 and 2030, working 5 years in advance on some projects.
- Customer diversification goal: Management aims to decentralize the customer base from the current 3–4 high-value customers to at least 8–10 high-value customers.
Maini: "Today, it's a question of choice from our side rather than a constraint. And like I've said, the market is quite large. And therefore, you also, don't want to disappoint a lot of customers. So, you want to make sure that you have something more than you can grow, but not go and do something where you will disappoint customers in execution."
Capacity Expansion & Capex
- Greenfield on track: Groundwork at the Gudipalli facility near Bangalore Airport is on track, with an advanced training and production facility being set up ahead of schedule nearby. Commercial production is targeted for late 2027.
- Capex plan progressing: The ₹1,000 crores 5-year capex plan is progressing swiftly on schedule.
- Existing facility stretch: The existing facility was previously estimated at ₹600 crores revenue capacity; improvements under the "Parivartan" mandate are now expected to push it beyond ₹600 crores.
- New facility ramp will be slow: Management expects the new facility to start with up to 6 months of approval processes, suggests looking at FY28 for revenue contribution, and notes ramp-up will be slow.
- Vertical integration at Andhra: The company is adding special processes and heat treatment at the Andhra facility for vertical integration, supporting the goal to move up the value chain with an increasing mix of critical components and subassemblies.
New Businesses & Inorganic Optionality
- Defence production commenced: Mass production of precision defence components began in Q1. Mr. Bhanu Prakash Srivastava, erstwhile CXO from BEL, has joined for the defence business.
- Medical certification received: The company received certification for making medical components (titanium and stainless steel) on the day of the call (August 7, 2026). Strategy disclosure is deferred to next quarter.
- Build-to-spec certification: The company has obtained build-to-spec design certification, supporting progression up the value chain.
- Aftermarket rollout in Q2: Automotive aftermarket product line is scheduled for commercial rollout in Q2 of FY27, leveraging the OEM-grade manufacturing ecosystem. Combining Tools and Hardware with aftermarket is expected to create "massive synergies" via brand and market leverage.
- Warrants for M&A flexibility: A preferential issue/warrants raised recently provides additional flexibility for inorganic opportunities across aerospace, auto components, and defence segments. Management evaluates targets as business-as-usual and will inform the market when something definitive emerges.
- Defence strategy pending: Management is working on the defence segment strategy and expects to share details in the next quarter or two.
Margin Outlook & Consolidated Trends
- Consolidated margin momentum: Management expects EBITDA margins to maintain the same trend shown at the consolidated level, with trends better than the previous year.
- Operating leverage is durable: Q1 margin improvement was driven by operating leverage from significant revenue rise YoY plus product mix gains. Operating leverage will continue; product mix may fluctuate quarter-to-quarter.
- Aerospace mix will keep rising: Aerospace share of revenue will marginally keep increasing quarter-on-quarter given its smaller base and higher growth rate.
- No consolidated growth commitment: Management declined to commit to 20%+ consolidated growth, saying the ambition is higher growth but refusing to be pulled into a number.
Maini: "I mean that's always going to be the ambition, but I won't be pulled into any number at this stage."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Aerospace organic growth | 25% growth; Q1 exceeded it | FY27 |
| Aerospace EBITDA margin | Stabilize as new programs reach steady-state; ~25% at mature level | Mature level, no date |
| Precision Technology EBITDA margin | 12%–13% | Near term |
| Automotive aftermarket rollout | Commercial launch of aftermarket product line | Q2 FY27 |
| Andhra Pradesh greenfield | Commercial production | Late 2027 |
| Capex plan | ₹1,000 crores 5-year plan | On schedule |
| Customer diversification | From 3–4 to 8–10 high-value customers | No date |
| Defence strategy disclosure | Share segment strategy | Next quarter or two |
| Medical components strategy | Share strategy or business plan | Next quarter |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Total income | ₹628 crores, up 13% YoY from ₹555 crores |
| EBITDA | ₹100 crores, up 14% YoY from ₹87 crores |
| EBITDA margin | 15.9%, versus 15.7% in Q1 FY26 |
| Net cash surplus | ₹129 crores as of June 2026, net debt-free |
| Aerospace and Defence revenue | ₹123 crores, up 40% YoY from ₹87 crores |
| Aerospace and Defence EBITDA | ₹26 crores, up 25% YoY from ₹21 crores |
| Aerospace and Defence EBITDA margin | 21.2%, versus 23.7% in Q1 FY26 |
| Aerospace order book | ₹5,960-plus crores, 10-year horizon |
| Aerospace active RFQ pipeline | ₹1,632 crores |
| Precision Technology and Auto Components revenue | ₹444 crores, up 11% YoY from ₹398 crores |
| Precision Technology and Auto Components EBITDA | ₹61 crores, up 46% YoY from ₹42 crores |
| Precision Technology and Auto Components EBITDA margin | 13.8%, versus 10.6% in Q1 FY26 |
| Aerospace growth commitment | 25% for FY27, exceeded in Q1 |
| 5-year capex plan | ₹1,000 crores, ₹510 crores aerospace and ₹430 crores auto |
| Aerospace top 3 customer concentration | 40% to 45% of order book |